Kimura (Doxazosin Mesilate)

Doxazosin mesilate selectively blocks alpha‑1 adrenergic receptors on vascular and prostatic smooth muscle. This inhibition prevents norepinephrine‑induced contraction, leading to arterial dilation that lowers blood pressure and to prostate muscle relaxation that improves urinary flow.

The appropriate dose of Kimura is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and any concomitant medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of doxazosin mesilate in pregnancy and lactation has not been clearly established. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To request Kimura, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑selective alpha blockers, doxazosin offers a more targeted alpha‑1 blockade, resulting in fewer reflex tachycardia effects. Unlike some calcium‑channel blockers, it also provides benefit for BPH symptoms, making it a dual‑purpose option for patients needing both blood‑pressure control and prostate relief.

Kimura should be stored at ambient temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not store in bathrooms or other humid environments.

Kimura is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to maintain consistent absorption and therapeutic effect.

The most serious risks include severe hypotension, which can lead to fainting, and rare events such as priapism or angioedema that require immediate medical attention. Patients should be educated to recognize these signs and seek urgent care if they occur.

Kimura is contraindicated in individuals with known hypersensitivity to doxazosin or any component of the formulation, and it should be avoided in patients with severe hepatic impairment or those taking medications that may cause dangerous additive blood‑pressure lowering without close monitoring.